Δ9-tetrahydrocannabinol, a cannabis sativa–derived natural product, as a probe of endocannabinoid system plasticity in type 1 diabetes: a receptor-level, testable hypothesis
Type 1 diabetes (T1D) is a chronic autoimmune disease in which receptor-level regulation of the endocannabinoid system (ECS) remains largely unmapped. While ECS perturbations have been extensively described in obesity and type 2 diabetes, a directed experimental interrogation of receptor adaptabilit...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2026-07-01
|
| Edice: | Frontiers in Natural Products |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fntpr.2026.1812441/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|